92 related articles for article (PubMed ID: 21099352)
1. The TOLL of inflammation in multiple myeloma.
Bell JK
Cancer Biol Ther; 2011 Jan; 11(1):68-70. PubMed ID: 21099352
[No Abstract] [Full Text] [Related]
2. Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack.
Bao H; Lu P; Li Y; Wang L; Li H; He D; Yang Y; Zhao Y; Yang L; Wang M; Yi Q; Cai Z
Cancer Biol Ther; 2011 Jan; 11(1):58-67. PubMed ID: 21248470
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop.
Bagratuni T; Sklirou AD; Kastritis E; Liacos CI; Spilioti C; Eleutherakis-Papaiakovou E; Kanellias N; Gavriatopoulou M; Terpos E; Trougakos IP; Dimopoulos MA
Sci Rep; 2019 Mar; 9(1):3245. PubMed ID: 30824741
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and multiple myeloma: the Toll connection.
Mantovani A; Garlanda C
Leukemia; 2006 Jun; 20(6):937-8. PubMed ID: 16721383
[No Abstract] [Full Text] [Related]
6. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells.
Vincent L; Jin DK; Karajannis MA; Shido K; Hooper AT; Rashbaum WK; Pytowski B; Wu Y; Hicklin DJ; Zhu Z; Bohlen P; Niesvizky R; Rafii S
Cancer Res; 2005 Apr; 65(8):3185-92. PubMed ID: 15833849
[TBL] [Abstract][Full Text] [Related]
7. The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma.
Abdi J; Engels F; Garssen J; Redegeld F
Crit Rev Oncol Hematol; 2011 Nov; 80(2):225-40. PubMed ID: 21236697
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors mediate proliferation and survival of multiple myeloma cells.
Bohnhorst J; Rasmussen T; Moen SH; Fløttum M; Knudsen L; Børset M; Espevik T; Sundan A
Leukemia; 2006 Jun; 20(6):1138-44. PubMed ID: 16617319
[TBL] [Abstract][Full Text] [Related]
9. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ.
Okuyama H; Tominaga A; Fukuoka S; Taguchi T; Kusumoto Y; Ono S
Oncol Rep; 2017 Feb; 37(2):684-694. PubMed ID: 28075473
[TBL] [Abstract][Full Text] [Related]
10. Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization.
Kim YS; Park ZY; Kim SY; Jeong E; Lee JY
Chem Biol Interact; 2009 Nov; 182(1):59-66. PubMed ID: 19627980
[TBL] [Abstract][Full Text] [Related]
11. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.
Kelly MG; Alvero AB; Chen R; Silasi DA; Abrahams VM; Chan S; Visintin I; Rutherford T; Mor G
Cancer Res; 2006 Apr; 66(7):3859-68. PubMed ID: 16585214
[TBL] [Abstract][Full Text] [Related]
12. Stenotic aortic valves have dysfunctional mechanisms of anti-inflammation: implications for aortic stenosis.
Lee JH; Meng X; Weyant MJ; Reece TB; Cleveland JC; Fullerton DA
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):481-6. PubMed ID: 21241861
[TBL] [Abstract][Full Text] [Related]
13. LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production.
Heo SK; Yun HJ; Noh EK; Park WH; Park SD
Immunol Lett; 2008 Oct; 120(1-2):57-64. PubMed ID: 18675302
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors.
Jego G; Bataille R; Geffroy-Luseau A; Descamps G; Pellat-Deceunynck C
Leukemia; 2006 Jun; 20(6):1130-7. PubMed ID: 16628189
[TBL] [Abstract][Full Text] [Related]
15. Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.
Murphy MB; Xiong Y; Pattabiraman G; Manavalan TT; Qiu F; Medvedev AE
J Leukoc Biol; 2015 Dec; 98(6):963-74. PubMed ID: 26310831
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 in acute viral infection: Too much of a good thing.
Olejnik J; Hume AJ; Mühlberger E
PLoS Pathog; 2018 Dec; 14(12):e1007390. PubMed ID: 30571771
[No Abstract] [Full Text] [Related]
17. Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier.
Grasedieck S; Panahi A; Jarvis MC; Borzooee F; Harris RS; Larijani M; Avet-Loiseau H; Samur M; Munshi N; Song K; Rouhi A; Kuchenbauer F
Leukemia; 2024 May; 38(5):1172-1177. PubMed ID: 38461190
[TBL] [Abstract][Full Text] [Related]
18. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
[TBL] [Abstract][Full Text] [Related]
19. GP130 cytokines, interferon, survival and proliferation of human myeloma cells.
Klein B
Eur Cytokine Netw; 1997 Sep; 8(3):323. PubMed ID: 9346376
[No Abstract] [Full Text] [Related]
20. Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes.
Campo GM; Avenoso A; Campo S; Traina P; D'Ascola A; Calatroni A
Arch Biochem Biophys; 2009 Nov; 491(1-2):7-15. PubMed ID: 19800307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
